Inhibiting the VIM-2 Metallo-β-Lactamase by Graphene Oxide and Carbon Nanotubes

被引:22
|
作者
Huang, Po-Jung Jimmy [1 ]
Pautler, Rachel [1 ]
Shanmugaraj, Jenitta [1 ]
Labbe, Genevieve [1 ]
Liu, Juewen [1 ]
机构
[1] Univ Waterloo, Dept Chem, Waterloo Inst Nanotechnol, Waterloo, ON N2L 3G1, Canada
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
graphene; beta-lactamases; inhibition; adsorption; carbon nanotubes; nanomaterials; PSEUDOMONAS-AERUGINOSA; GOLD NANOPARTICLES; ENZYME-ACTIVITY; MEMBRANES;
D O I
10.1021/acsami.5b01954
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Metallo-beta-lactamases (MBLs) degrade a broad spectrum of antibiotics including the latest carbapenems. So far, limited success has been achieved in developing its inhibitors using small organic molecules. VIM-2 is one of the most studied and important MBLs. In this work, we screened 10 nanomaterials, covering a diverse range of surface properties including charge, hydrophobicity, and specific chemical bonding. Among these, graphene oxide and carbon nanotubes are the most potent inhibitors, while most other materials do not show much inhibition effect. The inhibition is noncompetitive and is attributed to the hydrophobic interaction with the enzyme. Adsorption of VIM-2 was further probed using protein displacement assays where it cannot displace or be displaced by bovine serum albumin (BSA). This information is useful for rational design inhibitors for MBLs and more specific inhibition might be achieved by further surface modifications on these nanocarbons.
引用
收藏
页码:9898 / 9903
页数:6
相关论文
共 50 条
  • [41] Identification of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from dogs with pyoderma and otitis in Korea
    Hyun, Jae-Eun
    Chung, Tae-Ho
    Hwang, Cheol-Yong
    VETERINARY DERMATOLOGY, 2018, 29 (03) : 186 - +
  • [42] First Detection of VIM-2 Metallo-β-Lactamase-Producing Pseudomonas putida in Blattella germanica Cockroaches in an Algerian Hospital
    Loucif, Lotfi
    Cherak, Zineb
    Chamlal, Naima
    Bendjama, Esma
    Gacemi-Kirane, Djamila
    Grainat, Nadia
    Rolain, Jean-Marc
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (08)
  • [43] VIM-1 metallo-β-lactamase in Acinetobacter baumannii
    Tsakris, Athanassios
    Ikonomidis, Alexandros
    Pournaras, Spyros
    Tzouvelekis, Leonidas S.
    Sofianou, Danai
    Legakis, Nicholas J.
    Maniatis, Antonios N.
    EMERGING INFECTIOUS DISEASES, 2006, 12 (06) : 981 - 983
  • [44] Kinetic, Thermodynamic, and Crystallographic Studies of 2-Triazolylthioacetamides as Verona Integron-Encoded Metallo-β-Lactamase 2 (VIM-2) Inhibitor
    Xiang, Yang
    Zhang, Yue-Juan
    Ge, Ying
    Zhou, Yajun
    Chen, Cheng
    Wahlgren, Weixiao Yuan
    Tan, Xiangshi
    Chen, Xi
    Yang, Ke-Wu
    BIOMOLECULES, 2020, 10 (01)
  • [45] Providencia stuartii with VIM-1 metallo-β-lactamase
    Miriagou, V.
    Tzouvelekis, L. S.
    Flevari, K.
    Tsakiri, M.
    Douzinas, E. E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (01) : 183 - 184
  • [46] Discovery of Novel Inhibitor Scaffolds against the Metallo-β-lactamase VIM-2 by Surface Plasmon Resonance (SPR) Based Fragment Screening
    Christopeit, Tony
    Carlsen, Trine Josefine O.
    Helland, Ronny
    Leiros, Hanna-Kirsti S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (21) : 8671 - 8682
  • [47] First report of VIM-2 metallo-β-lactamases producing Pseudomonas aeruginosa isolates in Morocco
    Maroui, Itto
    Barguigua, Abouddihaj
    Aboulkacem, Asmae
    Ouarrak, Khadija
    Sbiti, Mohammed
    Louzi, Housssain
    Timinouni, Mohammed
    Belhaj, Abdelhaq
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2016, 22 (03) : 127 - 132
  • [48] First Report of an Extensively Drug-Resistant VIM-2 Metallo-β-Lactamase- Producing Brevundimonas diminuta Clinical Isolate
    Almuzara, Marisa N.
    Barberis, Claudia M.
    Rodriguez, Carlos H.
    Famiglietti, Angela M. R.
    Ramirez, Maria S.
    Vay, Carlos A.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (08) : 2830 - 2832
  • [49] First identification of an Escherichia coli clinical isolate producing both metallo-β-lactamase VIM-2 and extended-spectrum β-lactamase IBC-1
    Galani, I
    Souli, M
    Chryssouli, Z
    Katsala, D
    Giamarellou, H
    CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (08) : 757 - 760
  • [50] Multidrug-resistant Pseudomonas aeruginosa producing PER-1 extended-spectrum serine-β-lactamase and VIM-2 metallo-β-lactamase
    Docquier, JD
    Luzzaro, F
    Amicosante, G
    Toniolo, A
    Rossolini, GM
    EMERGING INFECTIOUS DISEASES, 2001, 7 (05) : 910 - 911